Home › Funds › a16z Capital Management, L.L.C. › CAMP
a16z Capital Management, L.L.C. position in CAMP
CAMP4 THERAPEUTICS CORP · Health Care
a16z Capital Management, L.L.C. reported holding 2,125,339 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$9.3M, representing 0.07% of its reported portfolio and ranking #15 among its reported holdings. a16z Capital Management, L.L.C. has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How a16z Capital Management, L.L.C.'s CAMP position evolved
a16z Capital Management, L.L.C. first disclosed a stake in CAMP in Q4 2024 at 2,125,339 shares (US$11.1M). The position peaked in Q4 2025 at 2,125,339 shares, worth US$13.0M. Across 7 filings, a16z Capital Management, L.L.C. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,125,339 shares valued at US$9.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 2.13M | $11.09M | New |
| Q1 2025 | 2.13M | $8.50M | Hold |
| Q2 2025 | 2.13M | $3.08M | Hold |
| Q3 2025 | 2.13M | $6.38M | Hold |
| Q4 2025 | 2.13M | $13.03M | Hold |
| Q1 2026 | 2.13M | $9.37M | Hold |
| Q2 2026 | 2.13M | $9.29M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAMP and 13F data
CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$18.6M), Trails Edge Capital Partners, LP (US$8.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAMP
- 5AM Venture Management, LLC 5.87M sh · $25.65M · Q2 2026
- Vivo Capital, LLC 4.25M sh · $18.56M · Q2 2026
- Trails Edge Capital Partners, LP 1.93M sh · $8.45M · Q2 2026
- Enavate Sciences GP, LLC 1.43M sh · $6.23M · Q2 2026
- Stonepine Capital Management, LLC 1.39M sh · $6.07M · Q2 2026
- HARBOURVEST PARTNERS LLC 1.27M sh · $5.56M · Q2 2026
More on a16z Capital Management, L.L.C.
FAQ
How long has a16z Capital Management, L.L.C. held CAMP?
a16z Capital Management, L.L.C. has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is a16z Capital Management, L.L.C.'s current position in CAMP?
As of Q2 2026, a16z Capital Management, L.L.C. holds 2.13M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $9.29M, representing 0.07% of its reported portfolio and ranking #15.
Has a16z Capital Management, L.L.C. been buying or selling CAMP?
In the latest 13F filing (Q2 2026), a16z Capital Management, L.L.C. held unchanged its position in CAMP. The position peaked in Q4 2025 at 2.13M shares.
Which other funds hold CAMP?
Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, Trails Edge Capital Partners, LP, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.